Among many ever-evolving weight loss strategies, various methods have emerged claiming to aid in shedding pounds quickly and effectively
How it works Clinical evidence Comparison with other GLP-1s Market outlook References Further reading Orforglipron, the first promising oral small-molecule GLP-1, is demonstrating weight-loss and metabolic results that could reshape obesity treatment and challenge injectable standards
Nature 495 , 107110 (2013)
Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML
Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I et al
Ultimately, we need to conduct more human trials to gain a clearer understanding of the efficacy of BPC-157 and its potential risks